Hannah Kerr-Peterson's practice focuses on the pharmaceutical and medical devices sectors, where she advises on UK and EU regulatory and contentious matters. Ms. Kerr-Peterson has experience advising on a broad range of issues which can develop over the course of a medicinal product's life cycle, including drug development, clinical trials, authorisation, pricing and reimbursement, pharmacovigilance and product liability.

Before joining the firm, Ms. Kerr-Peterson conducted pre-clinical research at a leading European research institute. She has also spent time in-house in the regulatory litigation team of a major aircraft manufacturer, where she predominantly assisted with international trade disputes.

Ms. Kerr-Peterson has a varied pro bono practice, where she has assisted a junior bank manager in respect of enforcement proceedings which were being pursued by the Financial Conduct Authority, and most recently an employment tribunal case regarding discriminatory treatment of a long-term employee. Ms. Kerr-Peterson is also an active member of the firm's Diversity Committee.


  • Amicus Therapeutics, Inc. (Case T-33/17) in a dispute concerning transparency of clinical trial data and access to documents held by the European Medicines Agency.
  • Global pharmaceutical company in an internal investigation following its identification of failures in its pharmacovigilance system.
  • Senior executives of a global pharmaceutical company in relation to an investigation into alleged bribery and corruption.
  • Advising pharmaceutical companies in relation to promotional activities: advising on compliance with EU and UK legislation and industry codes of practice; and coordinating multi-jurisdictional projects.
  • Major aircraft manufacturer in a contract dispute concerning misrepresentation, negligent misstatement and breach of contract.


2019 Regulatory Boot Camp
Arnold & Porter's Future Pharma Forum, London, United Kingdom
MHRA's updated guidance on a hard-Brexit
BioSlice Blog
MedTech Europe requests extension to the transition period for the MDR
BioSlice Blog
Update to ABHI Code of Practice
BioSlice Blog
Update on the EMA's Policy on Publication of Clinical Data
BioSlice blog


  • Legal Practice Course, The University of Law, 2015
  • Graduate Diploma in Law, BPP University, London, 2013
  • BSc (Hons), Pharmacology and Molecular Genetics, King's College London, 2012
  • England and Wales

Email Disclaimer